Loading...
•
Jun 30, 2024
NHI Q2 2024 Earnings Report
NHI reported strong second quarter results, exceeding expectations and leading to an increased full-year guidance.
Key Takeaways
National Health Investors, Inc. (NHI) announced its Q2 2024 results, with net income per diluted share at $0.81, NAREIT FFO per diluted share at $1.18, and Normalized FFO per diluted share also at $1.18. The company is raising its full-year guidance based on strong quarterly results and visibility into the second half of the year.
Net income attributable to common stockholders per diluted common share was $0.81.
NAREIT FFO per diluted common share was $1.18.
Normalized FFO per diluted common share was $1.18.
Normalized FAD was $51.8 million.
Revenue by Segment
Forward Guidance
NHI is updating its 2024 annual guidance range.
Positive Outlook
- NAREIT FFO per diluted common share to a range of $4.50- $4.54 from $4.36 - $4.41
- Normalized FFO per diluted common share to a range of $4.52- $4.56 from $4.37 - $4.43
- Normalized FAD to a range of $200.1 million - $201.8 million from $196.7 million - $199.2 million
- SHOP NOI growth in a range of 25%-30% year over year
- Continued collection of deferred rents
Challenges Ahead
- Continued rent concessions, asset dispositions and loan repayments
- Continued fulfillment of existing commitments
- No incremental benefit from unidentified acquisitions
- Guidance range is based on several assumptions, many of which are outside the Company’s control and all of which are subject to change
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...